About: Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1994 (uk) article scientifique publié en 1994 (fr) im Juni 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1994 (ast) scientific article published on 01 June 1994 (en)
publication date	wds:Q72679640-360CD8A4-B94F-4AF3-BC7C-D32C1D91F1A3
publication date	1994-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72679640-17188107-4140-47AE-93BA-BC7E71A570C1
language of work or name	English
cites work	wds:Q72679640-341872D3-AAB6-444E-A8AA-56FCD4F3D228 wds:Q72679640-37A8B2B9-6949-4BFC-95D5-B621742354AD wds:Q72679640-83D2BF10-35F1-4C6B-8EAE-B2231224BC5F wds:Q72679640-88A14ABC-E181-4C19-BC00-E5B0623DA189 wds:Q72679640-E5A57886-F5DC-48CD-A733-978DF6ACBE27
cites work	Isolation of a candidate human hematopoietic stem-cell population Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Intensive Treatment in order to Minimize the Ph-Positive Clone in Chronic Myelogenic Leukemia
author name string	wds:Q72679640-29504DC9-C0AA-4EED-96E4-59B0DFB2A630 wds:Q72679640-475F13BE-2F79-4EA3-A4B4-AEBA13551BE7 wds:Q72679640-51A43D1D-5384-4F27-AF2F-019FD2D2E830 wds:Q72679640-5D6D5888-EEFA-4C03-ADA8-24A4325BAABC wds:Q72679640-7A06F5C7-3BBD-4B45-AE5E-D55240D2FF15 wds:Q72679640-7EAE0CB1-5238-4C46-90C2-B5E495086143 wds:Q72679640-855DADD3-2E1B-4D72-B1AC-F9C8E0EF10EA wds:Q72679640-DF9DE74F-0CF3-4144-AB4E-B2C6647C4767
author name string	J Goldman M Barnett J Reiffers B Simonsson A Deisseroth D Aeppli P B McGlave A Carella
rdfs:label	Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (en) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (nl)
skos:prefLabel	Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (en) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (nl)
name	Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (en) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (nl)
author	wds:Q72679640-49B4DBFC-E904-4C88-A16A-7D49B1BEDC50
author	Paolo de Fabritiis
title	wds:Q72679640-A731F9CE-CAA1-495E-9606-ECE3E4301715
title	Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups (en)
page(s)	wds:Q72679640-FE32ED7A-6D51-479A-B5FE-D628BEB9A96F
page(s)	1486-1488
instance of	wds:Q72679640-8186A627-2BDB-4D34-9061-FE7CB5CC0C04
instance of	scholarly article
PubMed ID	wds:Q72679640-6A3AAC0A-0D1C-4595-A880-B2B17C88A4AC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7911185
PubMed ID	7911185
published in	wds:Q72679640-DFE809CF-455F-4F3F-AB91-49E6F4B98258
published in	The Lancet
issue	wds:Q72679640-BF44BA4A-4CD1-4F71-A422-DD61C4A8C5D9
volume	wds:Q72679640-2F3F7CFB-9EB7-46A7-8ED6-C15B9E96EC34
issue	8911
volume	343
DOI	wds:Q72679640-BB495EA8-C300-4A6F-8DCF-BE2CD8F09C66
DOI	http://dx.doi.org/10.1016/S0140-6736(94)92589-5
DOI	10.1016/S0140-6736(94)92589-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72679640
is cites work of	Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Biology of chronic myelogenous leukemia The role of hematopoietic growth factors in transfusion medicine. The molecular detection of circulating tumour cells Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings Innovative therapy for chronic myelogenous leukemia Autologous transplantation of in vivo purged PBSC in CML: comparison of FISH, cytogenetics, and PCR detection of Philadelphia chromosome in leukapheresis products Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation. Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance? High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. Interferon-alfa for chronic myeloid leukemia Autografting as first line treatment for chronic myeloid leukaemia Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens Autologous transplantation for the treatment of chronic myelogenous leukemia Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspective. [Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications] Autografting for chronic myeloid leukaemia Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma Treatment of chronic myeloid leukaemia: some topical questions Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging Overview of autologous stem cell transplantation. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software